Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better.
Share
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but the vaccine maker has more to offer, according to Oppenheimer analysts.
Continue reading this article with a Barron’s subscription.
Treasuries Gain as Key Fed Inflation Figures Trail Estimates
Stocks tanked after the Fed signaled fewer rate cuts next year. Here’s what Wall Street analysts see ahead.
Stock market today: Dow, S&P 500, Nasdaq clobbered as Fed, Powell signal fewer rate cuts in 2025
Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better.
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but the vaccine maker has more to offer, according to Oppenheimer analysts.
Continue reading this article with a Barron’s subscription.
View Options
Source link
Treasuries Gain as Key Fed Inflation Figures Trail Estimates
Stocks tanked after the Fed signaled fewer rate cuts next year. Here’s what Wall Street analysts see ahead.
Stock market today: Dow, S&P 500, Nasdaq clobbered as Fed, Powell signal fewer rate cuts in 2025
Robert Kiyosaki Warns Baby Boomers Will Be ‘Biggest Losers’– Suggests Kids ‘Nudge’ Parents To Sell Their Homes, Stocks And Bonds ‘Now’